Latest News about MRNA
Recent news which mentions MRNA
‘Black and Hispanic people have been less likely than their white counterparts to receive a vaccine’
January 14, 2022
From MarketWatch
NVAX Stock Alert: Why Is Novavax Plunging Today?
January 14, 2022
From InvestorPlace
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 14, 2022
From Benzinga
From MarketWatch
7 Undervalued Stocks to Buy Before Wall Street Catches On
January 14, 2022
From InvestorPlace
What's Going On With Moderna, BioNTech And Novavax Stock Today
January 13, 2022
From Benzinga
7 Hot Stocks to Pounce on if Their Prices Drop
January 13, 2022
From InvestorPlace
From Benzinga
These S&P 500 stocks have cratered, but analysts think 12 can turn it around with rebounds of up to 70%
January 13, 2022
From MarketWatch
Novavax Stock: Buy, Sell, or Hold in 2022?
January 13, 2022
From Motley Fool
5 Reasons Why Pfizer Is a Better Stock to Buy Right Now Than Moderna
January 13, 2022
From Motley Fool
The Top 10 Best-Performing Stocks of 2021
January 12, 2022
From InvestorPlace
WHO's Technical Body Says Updated COVID-19 Vaccines Needed To Combat Omicron: Reuters
January 12, 2022
From Benzinga
Which Vaccine Stocks Will Make You a Fortune in 2022?
January 12, 2022
From Motley Fool
Moderna COVID-19 Shot Lowers Risk Of Infection, Hospitalization Compared To Pfizer's, VA Real-World Data Shows
January 11, 2022
From Benzinga
Is Now The Time to Buy Shares of Alexandria Real Estate Equities?
January 11, 2022
From Benzinga
2 Bargain Stocks You Can Buy Today and Hold Forever
January 11, 2022
From Motley Fool
Here are dozens of ‘cheap’ stocks that could be poised to outperform as U.S. rates start to rise
January 11, 2022
From MarketWatch
Why Novavax Stock Jumped 6.5% Higher Today
January 10, 2022
From Motley Fool
Moderna Attempts To Bounce Off Key Support Level: Technical Analysis
January 10, 2022
Tickers
MRNA
From Benzinga
From Benzinga
Dear NVAX Stock Fans, You Should Be Watching This Vaccine News
January 10, 2022
From InvestorPlace
Moderna At Annual J.P. Morgan Healthcare Conference, Inks Oncology Pact With Carisma Therapeutics
January 10, 2022
Tickers
MRNA
From Benzinga
Is This Vaccine Stock a Buy?
January 10, 2022
From Motley Fool
This Hot Growth Stock Is Still a Buy After Enormous Gains
January 10, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.